On mental health issues, Tananbaum recently acknowledged Mindstrong Health’s efforts to get better insight into individual with mental disorders through the use of smart devices. Mindstrong Health refers to a startup company that is focused on the utilization of smartphones in the diagnosis and treatment of various neuropsychiatric disorders. In a recent report published in the MassDevice Medical Network, Tananbaum was quoted claiming that the founding team of Mindstrong Health brings unprecedented insight into the most important challenges regarding the provision the community health care services for patients with cognitive health disorders. He further acknowledged the collective technical vision, leadership and experience of the three founders of Mindstrong Health – Tom, Rick, and Paul – as an innovative platform for health care professionals to enhance patient outcomes.
James B Tananbaum, popularly known on Medium.com as Jim Tananbaum, is the founder and Chief Executive Officer of Foresite Capital Management, a venture capital company that specializes in healthcare. Jim has led major investments in twenty one healthcare organizations such as Jazz Pharmaceuticals, Amerigroup, and Amira Pharmaceuticals (which was acquired by a company known as Bristol-Myers Squibb). Dr. Tananbaum was the founder and manager at Theravance Biopharma and GelTex Pharmaceuticals, a company which was acquired by Genzyme. In addition to serving in various management positions, Dr. Tananbaum has also served in the visiting committees and/or advisory boards at Yale School of Engineering and Havard-MIT HST program. He has outstanding academic qualifications having pursued various degree programs including B.S.E.E. and B.S., M.B.A. and M.D. from Yale University, Harvard Business School, and Havard Medical School respectively.
Dr. Tananbaum has steered Foresite Capital to greater success, and it is currently worth $1.1 billion in assets. He has over 20 years of experience in building and investing in healthcare organizations. As per the Peloton Therapeutics report, Tananbaum is an investment heavyweight having invested in various projects including Sierra Ventures and Prospect Venture Partner II and III. Moreover, the recent report published in the Business, Inc. claimed that Dr. Tananbaum has been named in the Forbes’ Midas List as one of the 100 best venture investors for three consecutive years. Visit officialjimtananbaum.com for more info.